Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 20Vitamin D Deficiency 17Prostatic Neoplasms 14Neoplasms 9Polycystic Ovary Syndrome 8Colonic Neoplasms 8Rectal Neoplasms 6Colorectal Neoplasms 6Myelodysplastic Syndromes 5Osteoporosis 4Leukemia, Lymphocytic, Chronic, B-Cell 4Cardiovascular Diseases 4Warts 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia 3Brain Neoplasms 3Adenomatous Polyps 3Pathologic Processes 2Pain 2Obesity 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Musculoskeletal Diseases 2Melanoma 2Male Urogenital Diseases 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Cholecalciferol × Clear all
NCT04677816 2026-04-14

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
50 enrolled
Breast

Vitamin D Deficiency, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡